{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:27:19Z","timestamp":1789129639358,"version":"build-2803163510"},"reference-count":69,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine (Lond.)"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.2217\/nnm-2018-0388","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T16:05:28Z","timestamp":1552665928000},"page":"835-850","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":54,"title":["Copper Complex Nanoformulations Featuring Highly Promising Therapeutic Potential in Murine Melanoma Models"],"prefix":"10.1080","volume":"14","author":[{"given":"Jacinta O","family":"Pinho","sequence":"first","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana D","family":"Amaral","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui E","family":"Castro","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia MP","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Casini","sequence":"additional","affiliation":[{"name":"School of Chemistry, Cardiff University, Main Building, Park Place, CardiffCF10 3AT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u00e7a","family":"Soveral","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Manuela","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"issue":"1","key":"e_1_3_4_3_1","first-page":"326","article-title":"Chemotherapy resistance mechanisms in advanced skin cancer","volume":"11","author":"Kalal BS","year":"2017","unstructured":"Kalal BS , UpadhyaD, PaiVR. Chemotherapy resistance mechanisms in advanced skin cancer. Oncol. Rev.11 (1), 326 (2017).","journal-title":"Oncol. Rev."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.01.028"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr400135x"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1039\/C6CC08100B"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr900247m"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2011.05.008"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2009.12.010"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986710793213751"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.5b00513"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401465m"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201300107"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1039\/C8MT00072G"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2018-9999"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2016.09.013"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160209152446"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.05.005"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S68861"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.13.118"},{"key":"e_1_3_4_21_1","first-page":"35","volume-title":"Drug Delivery Nanoparticles: Formulation and Characterization","author":"Cruz MEM","year":"2009","unstructured":"Cruz MEM , Sim\u00f5esSI, CorvoML, MartinsMB, GasparMM. Formulation of NPDDS for Macromolecules. In : Drug Delivery Nanoparticles: Formulation and Characterization. PathakY, ThassuD (Eds). Informa Healthcare, NY, USA, 35\u201349 (2009)."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/60879"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30708"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2006.10.018"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.02.040"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(01)00309-1"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(99)00248-5"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095833"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05261-x"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S111274"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2016-0086"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2015.06.008"},{"key":"e_1_3_4_34_1","volume-title":"Preparation of Liposomes (2nd Ed.)","author":"Lasch J","year":"2003","unstructured":"Lasch J , WeissigV, BrandlM. Preparation of Liposomes (2nd Ed.). Oxford University Press Inc., NY, USA (2003)."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.11.033"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2018.06.029"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9107"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1184-979"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1632"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342050-00002"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2012.09.037"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(97)78066-4"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/la063501s"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2008.05.051"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00064"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S150201"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2003.10.038"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2016.1247101"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2008.08.022"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2016.04.011"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.6b00865"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2005.04.014"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00370"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9752"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(99)00186-8"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1021\/jp1043943"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15016951"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2014.51"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0059-7"},{"issue":"12","key":"e_1_3_4_60_1","first-page":"22328","article-title":"Extraction and antioxidant activity of flavonoids of Morus nigra","volume":"8","author":"Feng R-Z","year":"2015","unstructured":"Feng R-Z , WangQ, TongW-Zet al. Extraction and antioxidant activity of flavonoids of Morus nigra. Int. J. Clin. Exp. Med.8 (12), 22328\u201322336 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4274(95)03390-7"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701595300"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070618"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0182-7"},{"key":"e_1_3_4_65_1","unstructured":"FDA-NIH Biomarker Working Group . BEST (Biomarkers EndpointS and other Tools) Resource (2016). www.ncbi.nlm.nih.gov\/books\/NBK326791\/."},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)00219-6"},{"key":"e_1_3_4_67_1","unstructured":"Charles River Laboratories . C57BL\/6 Mice (2011). www.criver.com\/files\/pdfs\/rms\/c57bl6\/rm_rm_d_c57bl6n_mouse.aspx."},{"issue":"6","key":"e_1_3_4_68_1","first-page":"729","article-title":"Inhibitory effect of cordycepin on experimental hepatic metastasis of B16-F0 mouse melanoma cells","volume":"27","author":"Sato A","year":"2013","unstructured":"Sato A , YoshikawaN, KuboEet al. Inhibitory effect of cordycepin on experimental hepatic metastasis of B16-F0 mouse melanoma cells. In Vivo (Brooklyn)27 (6), 729\u2013732 (2013).","journal-title":"In Vivo (Brooklyn)"},{"issue":"4","key":"e_1_3_4_69_1","first-page":"3031","article-title":"Systemic Lipoplatin infusion results in preferential tumor uptake in human studies","volume":"25","author":"Boulikas T","year":"2005","unstructured":"Boulikas T , StathopoulosGP, VolakakisN, VougioukaM. Systemic Lipoplatin infusion results in preferential tumor uptake in human studies. Anticancer Res.25 (4), 3031\u20133039 (2005).","journal-title":"Anticancer Res."},{"issue":"5","key":"e_1_3_4_70_1","first-page":"1201","article-title":"Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a Phase I\u2013II study","volume":"15","author":"Stathopoulos GP","year":"2006","unstructured":"Stathopoulos GP , BoulikasT, VougioukaM, RigatosSK, StathopoulosJG. Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients: a Phase I\u2013II study. Oncol. Rep.15 (5), 1201\u20131204 (2006).","journal-title":"Oncol. Rep."},{"issue":"4","key":"e_1_3_4_71_1","first-page":"589","article-title":"Pharmacokinetics and adverse reactions of a new liposomal cisplatin (lipoplatin): Phase I study","volume":"13","author":"Stathopoulos GP","unstructured":"Stathopoulos GP , BoulikasT, VougioukaMet al. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (lipoplatin): Phase I study. Oncol. Rep.13 (4), 589\u2013595.","journal-title":"Oncol. Rep."}],"container-title":["Nanomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/nnm-2018-0388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:50:50Z","timestamp":1716493850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/nnm-2018-0388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.2217\/nnm-2018-0388"],"URL":"https:\/\/doi.org\/10.2217\/nnm-2018-0388","relation":{},"ISSN":["1743-5889","1748-6963"],"issn-type":[{"value":"1743-5889","type":"print"},{"value":"1748-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=innm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-10-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}